To extend these findings and investigate the clinical relevance of PSAT1 in EGFR-mutant lung cancer, we analyzed microarray datasets from patients with EGFR-mutant lung tumors for a comparative expression analysis and correlation with clinical outcomes. The gene discussed is EGFR; the disease is lung cancer.